Description
The market opportunities for cancer treatments are at an all-time high but the publication rate of clinical trials is low due to factors such as flawed design and failure to meet endpoints. SMi`s Clinical Trials in Cancer 2010 conference will feature presentations from industry professionals and academic experts on managing clinical development in this crucial therapeutic area.
Now in its 9th year, Clinical Trials in Cancer 2010 has become an essential event for all those working in oncology in the pharamceutical sector. Attend to discover the latest thinking in adaptive trial designs, gain insight into cancer biomarkers, understand the challenges of translational medicine and hear case studies on the logistical and operational issues of conducting clinical trials in Europe.
